A Phase 1 Safety and Pharmacokinetic Study of PC-1005 (MIV-150/Zinc Acetate/Carrageenan Gel) Administered Rectally to HIV-1 Seronegative Adults
Phase of Trial: Phase I
Latest Information Update: 23 Jul 2018
At a glance
- Drugs MIV 150/zinc acetate (Primary)
- Indications HIV infections
- Focus Adverse reactions; Pharmacokinetics
- 16 Jul 2018 Status changed from not yet recruiting to recruiting.
- 14 May 2018 Planned initiation date changed from 1 Apr 2018 to 1 Jun 2018.
- 29 Jan 2018 New trial record